News: A new role for aspirin/ibuprofen in breast Ca?


Regular use of NSAIDs may reduce a woman's risk of breast Ca.

Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin and ibuprofen, may reduce a woman's risk for breast cancer, according to the results of a recent meta-analysis.

Researchers included a total of 38 studies (16 case–control, 18 cohort, three case–control nested in well-defined cohorts, and one clinical trial) performed in five countries, involving both COX-2–selective and –nonselective inhibitors.

Use of any NSAID was associated with about a 12% reduction in breast cancer risk (random effects pooled RR=0.88; 95% CI, 0.84–0.93). Aspirin or ibuprofen was associated with similar risk reductions (RR=0.87; 95% CI, 0.82–0.92; and RR=0.79; 95% CI, 0.64–0.97, respectively). In general, associations were stronger in case–control than in cohort studies, but the researchers noted that this may be due to recall bias.

Related Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
© 2024 MJH Life Sciences

All rights reserved.